Biden proposal to cap all insulin prices at $35 a month has little chance of passing Congress

Senate Republicans killed a proposal last year to cap out-of-pocket costs at $35 for people with private insurance. Source link

Read more

Outperforming asset manager picks the stocks set to win as margins get squeezed

Plurimi Wealth's Patrick Armstrong believes margin squeeze is the "biggest risk" for equities — but some stocks could beat the

Read more

Investment banks say it’s time to get back into China, with Goldman naming 10 top stocks

A number of Chinese stocks have plummeted over recent months, creating attractive entry points, according to Goldman Sachs. Source link

Read more